MC2-25 VLS is a first-in-class drug candidate for urea associated skin diseases using a di-peptide as an iso-cyanate scavenger to inhibit carbamylation of amino acids and proteins in the skin MC2-25 ...

ATLANTA, March 17, 2026--(BUSINESS WIRE)--OXOS Medical® today announced that its MC2 portable X-ray system is now cleared for pediatric imaging, enabling providers to deliver quality, low-dose X-ray ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MC2-03, a treatment candidate from MC2 Therapeutics, ...

OXOS Medical has received the US Food and Drug Administration (FDA) clearance for the MC2 portable X-ray for paediatric imaging. The clearance enables healthcare providers to provide low-dose, quality ...

We've seen plenty of inventors try and reinvent the bicycle, but there aren't many that take inspiration from the penny-farthing. The first MC2 caught our attention with its odd-sized wheels and multi ...